Sistemic is a product development company that leverages the instructive power of microRNA (miRNA) to provide leading-edge products for the Bioprocessing, Cell (and Stem Cell) Therapy, and Drug Discovery and Development markets. Sistemic provides a broad range of products from robust quality control (QC) for cells to toxicity and drug response based products for Pharmaceutical markets. These products are helping companies worldwide to deliver drugs and therapies successfully and in a cost-effective manner,whilst providing knowledge-rich and instructive data on a range of cell systems. Sistemic’s pioneering products are centred around the company’s IP and core expertise within three areas: robust miRNA profiling, superior statistical analytics and multi-layered contextual analysis. Together,these constitute the Sistemic Methodology. Sistemic leverages the instructive power of miRNA. MiRNAs are seen as the master controllers of a cell and provide information on the effects within a whole cell or organism rather than an isolated pathway. This systems approach means that the data produced is more indicative of the biology and more informative of actual effect. The Sistemic method provides a rigorous yet rapid understanding of the biological changes that occur within a cell. Resulting data allow companies to make well-informed decisions. This enables them to develop their cell (or stem cell) therapies and drug development pipelines more successfully and more cost effectively.
Company Growth (employees)
Glasgow, GB
Size (employees)
10 (est)
Sistemic was founded in 2009 and is headquartered in Glasgow, GB

Sistemic Office Locations

Sistemic has an office in Glasgow
Glasgow, GB (HQ)
West Of Scotland Science Park, Block 3, Unit's 3,4 & 5

Sistemic Metrics

Summary Metrics

Founding Date


Total Funding

$1 m

Latest funding size

$1 m

Time since last funding

about 7 years


Sistemic's latest funding round in March 2010 was reported to be $1 m. In total, Sistemic has raised $1 m

Sistemic Financial Metrics

Sistemic's revenue was reported to be £283.8 k in FY, 2014

Revenue (FY, 2014)

£283.8 k

Gross profit (FY, 2014)

£237.3 k

Gross profit margin (FY, 2014), %


Net income (FY, 2014)

(£348 k)

Cash (31-Dec-2016)

FY, 2014


£283.8 k

Cost of goods sold

£46.4 k

Gross profit

£237.3 k

Gross profit Margin, %


Operating expense total

£646.9 k

Pre tax profit

(£411.5 k)

Net Income

(£348 k)
FY, 2014FY, 2015FY, 2016


£74.2 k£8.1 k£717

Accounts Receivable

£71.6 k£3.7 k£1.2 k

Current Assets

£248 k£123.8 k£93.2 k


£16.2 k£16 k£23.4 k


£104.9 k£119.3 k£151.5 k

Total Assets

£369.1 k£259.2 k£268 k

Accounts Payable

£118.2 k£168.3 k£215.4 k

Current Liabilities

£144.5 k£207 k£473 k

Retained Earnings

(£348 k)

Total Equity

£92.5 k(£177.8 k)(£204.9 k)

Financial Leverage

4 x-1.5 x-1.3 x
FY, 2014

Income Taxes Paid

£63.5 k
Y, 2016

Financial Leverage

-1.3 x

Sistemic Online Presence

Sistemic Company Life

You may also be interested in